BioCorRx (OTCMKTS:BICX) Posts Quarterly Earnings Results

BioCorRx (OTCMKTS:BICX) released its earnings results on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports.

BioCorRx Stock Up 20.7 %

Shares of BioCorRx stock opened at $0.50 on Tuesday. BioCorRx has a 12-month low of $0.26 and a 12-month high of $1.50. The company has a market capitalization of $8.02 million, a price-to-earnings ratio of -0.96 and a beta of 0.57. The firm’s 50-day moving average price is $0.39 and its two-hundred day moving average price is $0.37.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.